Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial
Authors:
Open Access
- 28 July 2023
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (1) , 92-99
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trialTrials, 2020
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2018
- Management of febrile neutropaenia: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2016
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2012
- Monotherapy with Intravenous Followed by Oral High-Dose Ciprofloxacin versus Combination Therapy with Ceftazidime plus Amikacin as Initial Empiric Therapy for Granulocytopenic Patients with FeverAntimicrobial Agents and Chemotherapy, 2000
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancerCancer, 1993
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971